HUMA · Forms 3, 4, 5
Insider trades at Humacyte, Inc.
1 insider bought $30K of Humacyte, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Humacyte, Inc. (HUMA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| D Scott Coward | Director | Options or other derivatives | Form 4 | ||||
| Paul Brian Kuznik | Director | Options or other derivatives | Form 4 | ||||
| Paul Brian Kuznik | Director | Became an insider (Form 3) | Form 3 | ||||
| D Scott Coward | Director | Became an insider (Form 3) | Form 3 | ||||
| Keith Anthony Jones | Director | Buy | 10,000 | $0.56 | $6K | Form 4 | |
| Keith Anthony Jones | Director | Buy | 10,000 | $0.69 | $7K | Form 4 | |
| Keith Anthony Jones | Director | Buy | 30,000 | $0.59 | $18K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.